Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

132 questions in 24 reviews · Acute Respiratory Infections

current versions
No studies 132 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Magnesium sulphate + epinephrine vs no treatment or normal saline + epinephrine
Hospital re‐admission within 30 days of discharge · children up to 12 months old with acute bronchiolitis
Magnesium sulphate for treating acute bronchiolitis in children up to two years of age (2020) · Cochrane
no estimate extractedNRNo studies
Magnesium sulphate vs hypertonic saline
Time to recovery · children up to 12 months old with acute bronchiolitis
Magnesium sulphate for treating acute bronchiolitis in children up to two years of age (2020) · Cochrane
no estimate extractedNRNo studies
Magnesium sulphate vs hypertonic saline
Mortality · children up to 12 months old with acute bronchiolitis
Magnesium sulphate for treating acute bronchiolitis in children up to two years of age (2020) · Cochrane
no estimate extractedNRNo studies
Probiotic vs placebo
Severity of AOM · children up to age 18 years
Probiotics for preventing acute otitis media in children (2019) · Cochrane
no estimate extractedNRNo studies
Influenza vaccine vs placebo
Hospitalisations ‐ not reported · people aged over 65 years
Vaccines for preventing influenza in the elderly (2018) · Cochrane
no estimate extractedNRNo studies
Inactivated influenza vaccine vs placebo or do nothing
Number of parents having to take off work during · healthy, community‐dwelling children older than 2 years of age
Vaccines for preventing influenza in healthy children (2018) · Cochrane
no estimate extractedNRNo studies
Inactivated influenza vaccine vs placebo or do nothing
Hospitalisations ‐ not reported · healthy, community‐dwelling children older than 2 years of age
Vaccines for preventing influenza in healthy children (2018) · Cochrane
no estimate extractedNRNo studies
Inactivated influenza vaccine vs placebo or do nothing
Fever ‐ not reported · healthy, community‐dwelling children older than 2 years of age
Vaccines for preventing influenza in healthy children (2018) · Cochrane
no estimate extractedNRNo studies
Inactivated influenza vaccine vs placebo or do nothing
Nausea ‐ not reported · healthy, community‐dwelling children older than 2 years of age
Vaccines for preventing influenza in healthy children (2018) · Cochrane
no estimate extractedNRNo studies
Live attenuated influenza vaccine vs placebo or do nothing
Hospitalisation ‐ not reported · healthy, community‐dwelling children younger than 16 years of age
Vaccines for preventing influenza in healthy children (2018) · Cochrane
no estimate extractedNRNo studies
Live attenuated influenza vaccine vs placebo or do nothing
Nausea ‐ not reported · healthy, community‐dwelling children younger than 16 years of age
Vaccines for preventing influenza in healthy children (2018) · Cochrane
no estimate extractedNRNo studies
Honey vs dextromethorphan
Duration of cough · acute cough in children
Honey for acute cough in children (2018) · Cochrane
no estimate extractedNRNo studies
Honey vs diphenhydramine
Cough duration · acute cough in children
Honey for acute cough in children (2018) · Cochrane
no estimate extractedNRNo studies
Honey vs no treatment
Cough duration · acute cough in children
Honey for acute cough in children (2018) · Cochrane
no estimate extractedNRNo studies
Honey vs no treatment
Adverse events · acute cough in children
Honey for acute cough in children (2018) · Cochrane
no estimate extractedNRNo studies
Honey vs placebo
Adverse events · acute cough in children
Honey for acute cough in children (2018) · Cochrane
no estimate extractedNRNo studies
Honey vs salbutamol
Adverse events · acute cough in children
Honey for acute cough in children (2018) · Cochrane
no estimate extractedNRNo studies
Honey vs dextromethorphan
Adverse events · acute cough in children
Honey for acute cough in children (2018) · Cochrane
no estimate extractedNRNo studies
Cyclamen europaeum vs placebo
Proportion of participants with resolution or improvement of symptoms up to 30 days · adults with acute sinusitis
Cyclamen europaeum extract for acute sinusitis (2018) · Cochrane
no estimate extractedNRNo studies
Summary of findings for all doses of nasal decongestant vs placebo
Secondary outcome: All adverse events · adult patients with the common cold
Nasal decongestants in monotherapy for the common cold (2016) · Cochrane
no estimate extractedNRNo studies
Resistance and endurance exercise prior to influenza vaccination vs no exercise prior to influenza vaccination
Complications related to influenza illness · Adults and elderly
Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in… (2016) · Cochrane
no estimate extractedNRNo studies
Resistance and endurance exercise prior to influenza vaccination vs no exercise prior to influenza vaccination
Numbers of working days or days lost related to influenza illness · Adults and elderly
Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in… (2016) · Cochrane
no estimate extractedNRNo studies
Gamma‐globulin vs control (saline or no treatment)
Cases of congenital rubella infection ‐ not measured · susceptible people exposed to rubella
Post‐exposure passive immunisation for preventing rubella and congenital rubella syndrome (2015) · Cochrane
no estimate extractedNRNo studies
Gamma‐globulin vs control (saline or no treatment)
Cases of congenital rubella syndrome ‐ not measured · susceptible people exposed to rubella
Post‐exposure passive immunisation for preventing rubella and congenital rubella syndrome (2015) · Cochrane
no estimate extractedNRNo studies
Gamma‐globulin vs control (saline or no treatment)
Adverse events ‐ not measured · susceptible people exposed to rubella
Post‐exposure passive immunisation for preventing rubella and congenital rubella syndrome (2015) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Fever after initiation of treatment · elderly people with no influenza A infection (prevention) or with influenza A infection (treatment)
Amantadine and rimantadine for influenza A in children and the elderly (2014) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Cough after initiation of treatment · elderly people with no influenza A infection (prevention) or with influenza A infection (treatment)
Amantadine and rimantadine for influenza A in children and the elderly (2014) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Dizziness ( · elderly people with no influenza A infection (prevention) or with influenza A infection (treatment)
Amantadine and rimantadine for influenza A in children and the elderly (2014) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Mortality · adults and children with clinical signs and symptoms of acute lower respiratory tract infection
Chest radiographs for acute lower respiratory tract infections (2013) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Hospitalisation rates · adults and children with clinical signs and symptoms of acute lower respiratory tract infection
Chest radiographs for acute lower respiratory tract infections (2013) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Complications of infection · adults and children with clinical signs and symptoms of acute lower respiratory tract infection
Chest radiographs for acute lower respiratory tract infections (2013) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse effects from chest radiographs · adults and children with clinical signs and symptoms of acute lower respiratory tract infection
Chest radiographs for acute lower respiratory tract infections (2013) · Cochrane
no estimate extractedNRNo studies